Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Asciminib

Asciminib

Asciminib structure

Asciminib 

structure
  • CAS No:

    1492952-76-7

  • Formula:

    C20H18ClF2N5O3

  • Chemical Name:

    Asciminib

  • Synonyms:

    Asciminib (ABL-001);ABL-001 (ASCIMINIB);(R)-N- (4-(chlorodifluoromethoxy)phenyl)- 6-(3- hydroxypyrrolidin-1- yl)-5- (1H-pyrazol- 5-yl)nicotinamide;ABL-001;Asciminib;EOS-61420;L1F3R18W77;UNII-L1F3R18W77

  • Categories:

    Organic Chemistry  >  Amides

Description

Asciminib (ABL001) is a potent and selective allosteric Bcr-Abl inhibitor; inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.


ABL001 has been used in trials studying the health services research of Chronic Myelogenous Leukemia and Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.|Asciminib is an orally bioavailable, allosteric Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity. Designed to overcome resistance, ABL001 binds to the Abl portion of the Bcr-Abl fusion protein at a location that is distinct from the ATP-binding domain. This binding results in the inhibition of Bcr-Abl-mediated proliferation and enhanced apoptosis of Philadelphia chromosome-positive (Ph+) hematological malignancies. The Bcr-Abl fusion protein tyrosine kinase is an abnormal enzyme produced by leukemia cells that contain the Philadelphia chromosome.

Asciminib Basic Attributes

449.84

449.106628

L1F3R18W77

C114494

L - Antineoplastic and immunomodulating agents

Characteristics

103

1.5±0.1 g/cm3

335.8±31.5 °C

1.662

Drug Information

Treatment of chronic myeloid leukaemia

ABL001

Asciminib Use and Manufacturing

Human Drugs -> EU pediatric investigation plans|Human drugs -> Rare disease (orphan)

Computed Properties

Molecular Weight:449.8
XLogP3:3
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:6
Exact Mass:449.1066235
Monoisotopic Mass:449.1066235
Topological Polar Surface Area:103
Heavy Atom Count:31
Complexity:626
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Asciminib

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.